As MS patients and CR-EAE models express higher levels of circulating IL-8 and CXCL-1 [58, 59], the hepatic chemokine response may be involved in the control of leukocyte recruitment to chronic inflammatory lesions in the brain. The gene discussed is CXCL8; the disease is myeloid sarcoma.